Skip to Content

Research

PATRICIA

Research

Research

Clinicaltrial.gov identifier:
NCT02448420
Status:
Recruiting
Scenario:
Locally Advanced or Metastatic
Tumour subtype:
HER2+
Phase:
Phase II
Drug/Intervention:
Letrozole

A phase II study of palbociclib and trastuzumab with or without letrozole in previously treated, postmenopausal patients with HER2-positive metastatic breast cancer.

A phase II study of palbociclib and trastuzumab with or without letrozole in previously treated, postmenopausal patients with HER2-positive metastatic breast cancer.

Sponsors

SOLTI

Principal investigators

Eva M. Ciruelos Gil

Medical Oncologist, Medical Oncology Department, University Hospital 12 de Octubre, Madrid

X
Utilizamos cookies propias y de terceros para mejorar nuestros servicios mediante el análisis de sus hábitos de navegación. Puede cambiar la configuración u obtener más información aquí.